Lv61
2690 积分 2021-05-31 加入
Type I interferon-stimulated genes predict clinical response to belimumab in systemic lupus erythematosus
5分钟前
待确认
Additional benefits of belimumab in chronic phase of systemic lupus erythematosus and efficacy of tacrolimus combination therapy
9分钟前
待确认
Treat-to-target in SLE: is serology important? Results from an integrated analysis of five randomised clinical trials of belimumab
32分钟前
待确认
Infectious complications of Belimumab with standard care in systemic lupus erythematosus: a systematic review and meta-analysis
2小时前
待确认
Dual B-cell targeting in systemic lupus erythematosus: The role of combined and sequential therapy with rituximab and belimumab
2小时前
待确认
Dual benefit of belimumab in post-transplant lupus nephritis: Glucocorticoid withdrawal and extrarenal disease control
3小时前
待确认
Discontinuation of belimumab in systemic lupus erythematosus patients who achieved disease stability: a retrospective cohort study
3小时前
待确认
Commentary: Infectious complications of Belimumab with standard care in systemic lupus erythematosus: a systematic review and meta-analysis
3小时前
已关闭
Efficacy and safety of Belimumab, Rituximab and Voclosporin in the treatment of lupus nephritis based on registered clinical trials: A systematic review and network meta-analysis
4小时前
待确认
Safety and tolerability of combination rituximab and belimumab therapy in systemic lupus erythematosus: A systematic review
5小时前
待确认
Targeting macrophage liver X receptors by hydrogel‐encapsulated T0901317 reduces atherosclerosis without effect on hepatic lipogenesis
皖公网安备34019202002308
